Inventor
KLUGE ARTHUR
US19 patents
⚠️ This page may combine multiple inventors who share the name “KLUGE ARTHUR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MITOBRIDGE INC
10 patentsUS10766888B1Sep 8, 2020
HMOX1 inducers
MITOBRIDGE INC16 citations90
US10611790B2Apr 7, 2020
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
MITOBRIDGE INC11 citations85
US10479775B1Nov 19, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC7 citations83
US10399958B2Sep 3, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC7 citations83
US11578052B2Feb 14, 2023
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC1 citations72
US11034670B2Jun 15, 2021
Poly-ADP ribose polymerase (PARP) inhibitors
MITOBRIDGE INC2 citations72
US10906885B2Feb 2, 2021
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC1 citations72
US11993585B2May 28, 2024
Poly-ADP ribose polymerase (PARP) inhibitors
MITOBRIDGE INC0 citations62
US10968172B2Apr 6, 2021
USP30 inhibitors
MITOBRIDGE INC1 citations60
US10188627B2Jan 29, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC0 citations40
CELGENE AVILOMICS RES INC
3 patentsUS9040541B2May 26, 2015
4,6-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC5 citations84
US9393246B2Jul 19, 2016
4,6-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC3 citations73
US10662195B2May 26, 2020
Protein kinase conjugates and inhibitors
CELGENE AVILOMICS RES INC1 citations61